We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

National Survey on Hypertension in General Practitioner (GP) Consultation (Prophyl GP)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00695656
First Posted: June 12, 2008
Last Update Posted: August 6, 2009
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
AstraZeneca
June 10, 2008
June 12, 2008
August 6, 2009
April 2008
Not Provided
Demographic, clinical and health care characteristics [ Time Frame: Once ]
Same as current
Complete list of historical versions of study NCT00695656 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
National Survey on Hypertension in General Practitioner (GP) Consultation
Profile of Hypertensive Patients Seen in General Practitioner Consultation
To evaluate (with sufficient accuracy) the profile(demographic and clinical characteristics, health care management) of hypertensive patients seen in general practitioner consultation.
Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Probability Sample
First three consecutive patients with hypertension seen by general practitioner
Hypertension
Not Provided
1
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
2853
November 2008
Not Provided

Inclusion Criteria:

  • male or female > or = 18 years old
  • Known hypertension
  • agree to take part in this study

Exclusion Criteria:

Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
France
 
 
NCT00695656
NIS-CFR-DUM-2007/7
No
Not Provided
Not Provided
Alain Castaigne, Medical Director, AstraZeneca Pharmaceuticals
AstraZeneca
Not Provided
Study Director: Castaigne, Medical Director AstraZeneca
AstraZeneca
August 2009